Testing an Eye-Movement Vision Test for People With Tumors Near the Pituitary Gland
Original title: Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase was given for this study, so it is still an early test in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is checking whether a vision test called SONDA, which follows your eye movements, works well for people with a tumor in the area above the pituitary gland.
Who this trial is for. This trial is for people who have a supra sellar tumor, meaning a tumor in the area just above the pituitary gland. It is testing whether the SONDA visual field test is a good fit for these patients. A visual field test checks how much you can see around you without moving your eyes.
Where it stands. This trial has not reported results. It is looking at how suitable the SONDA test is for people with these tumors. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Tumors in this part of the head can press on the nerves that carry vision. Doctors check that with vision tests. This study is trying to find out if the SONDA test is a good way to do that check. If you have a tumor in this area, you could ask your care team about this study and about how your vision is being watched.
What it doesn't mean: This does not mean the SONDA test has been shown to work better than the tests used now. A trial is a test, not proven care. Taking part in a trial is not a guarantee that it will help you. And this is not a promise of a cure.
Source: ClinicalTrials.gov, July 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.